Huiyuan Zhang

ORCID: 0000-0002-1532-2462 · 1 paper in corpus
preprint 2023
·doi:10.21203/rs.3.rs-3509174/v1

Abstract Objective To investigate the efficacy and safety of dienogest((DNG) monotherapy and gonadotropin-releasing hormone agonist (GnRH-a) combined with DNG sequential treatment for adenomyosis. Methods This is a retrospective study.15…